HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of Lacidipine on Blood Pressure and Endothelial Function in Mild-to-Moderate Essential Hypertension Patients With Diabetes in Korea.

AbstractBACKGROUND AND OBJECTIVES:
The aim of this study was to evaluate the efficacy of lacidipine in reducing blood pressure (BP) and to determine its effect on endothelial function in mild-to-moderate hypertensive patients with type 2 diabetes mellitus (DM).
SUBJECTS AND METHODS:
This was a prospective, multicenter, open-label, single-arm study, enrolling 290 patients with mild-to-moderate hypertension and type 2 DM. Patients were initially treated with 2 mg lacidipine orally once daily for 4 weeks, which was then increased as necessary every 4 weeks to a maximal dose of 6 mg daily. The primary endpoint was the mean change in systolic blood pressure (SBP) from baseline after 12 weeks of treatment. Secondary endpoints included mean changes in diastolic blood pressure (DBP), flow-mediated vasodilatation (FMD), and serum concentrations of biochemical markers such as high-sensitivity C-reactive protein (hs-CRP), monocyte chemo-attractant protein-1 (MCP-1), matrix metalloproteinase-9 (MMP-9), and plasminogen activator inhibitor-1 (PAI-1).
RESULTS:
Lacidipine treatment significantly reduced SBP by -13.4±13.0 mmHg (p<0.001) and DBP by -6.2±9.3 mmHg (p<0.001). Lacidipine treatment did not improve endothelial-dependent vasodilatation, despite significantly improved nitroglycerin-induced, endothelial-independent vasodilatation. MCP-1 levels significantly decreased from 283.66±110.08 pg/mL to 257.83±100.23 pg/mL (p<0.001); whereas there were no significant changes in the levels of hs-CRP, MMP-9, or PAI-1.
CONCLUSION:
Twelve weeks of treatment with lacidipine was effective and well tolerated in mild-to-moderate hypertensive patients with type 2 DM. In spite of inducing a significant reduction in MCP-1 levels, lacidipine did not improve endothelial function.
AuthorsDae-Hee Kim, Il-Young Oh, Hae-Young Lee, Yong-Jin Kim, Hyo-Soo Kim, Cheol-Ho Kim, Byung-Hee Oh, Kwon-Sam Kim, Doo-Il Kim, Young-Dae Kim, Kyu-Hyung Ryu, Si-Hoon Park, Sang-Hong Baek, Dong-Gu Shin, Wan Joo Shim, Tae-Hoon Ahn, Seok-Kyu Oh, Seung-Hwan Lee, Sung-Yun Lee, Myung-Ho Jeong, Wook-Sung Chung, Jun-Young Jeong, So-Yeon Choi, Si-Wan Choi, Min-Su Hyon
JournalKorean circulation journal (Korean Circ J) Vol. 40 Issue 12 Pg. 632-8 (Dec 2010) ISSN: 1738-5555 [Electronic] Korea (South)
PMID21267385 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: